James S J Manuso's Net Worth
$318 Thousand
Who is James S J Manuso?
James S J Manuso does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CORTEX PHARMACEUTICALS INC/DE/, Ocuphire Pharma, Inc., and Astex Pharmaceuticals, Inc.
SEC CIK
James S J Manuso's CIK is 0001236365
Past Insider Trading and Trends
2020 was James S J Manuso's most active year for acquiring shares with 7 total transactions. James S J Manuso's most active month to acquire stocks was the month of December. 2013 was James S J Manuso's most active year for disposing of shares, totalling 22 transactions. James S J Manuso's most active month to dispose stocks was the month of September. 2013 saw James S J Manuso paying a total of $413,100.00 for 475,000 shares, this is the most they've acquired in one year. In 2013 James S J Manuso cashed out on 6,456,400 shares for a total of $571,340.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CORTEX PHARMACEUTICALS INC/DE/ (RSPI) Snapshot price: $0.00265
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.50% | 1.1K |
—
|
—
| 74.25K |
Sep 13 - Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +100.00% | 11.89M |
—
|
—
| 23.78M |
Apr 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4 - Mar 31
| |||
Form 4
|
∞
| 11.89M |
—
|
—
| 11.89M |
Aug 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ocuphire Pharma, Inc. (OCUP) Snapshot price: $1.2001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +45.26% | 41.14K |
—
|
—
| 132.04K |
Jun 11
| |||
Form 4
| +32.11% | 22.09K |
—
|
—
| 90.89K |
Jan 1
| |||
Form 4
| +18.98% | 10.98K |
—
|
—
| 68.8K |
Jun 6
| |||
Form 4
| +5.12% | 2.82K |
—
|
—
| 57.83K |
Apr 19
| |||
Form 4
| +50.85% | 18.54K |
—
|
—
| 55.01K |
Jan 11
| |||
Form 4
| +2.21% | 787 |
—
| $0.08 | 36.47K |
Oct 11
| |||
Form 4
| +65.41% | 14.11K |
—
|
—
| 35.68K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +30.18% | 5K |
$1.99 | $9,950.00 | 21.57K |
May 20
| |||
Form 4
| +13.73% | 2K |
$3.50 | $7,000.00 | 16.57K |
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +43.75% | 4.43K |
—
|
—
| 14.57K |
Nov 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
|
∞
| 10.14K |
—
|
—
| 10.14K |
Nov 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Astex Pharmaceuticals, Inc No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.97K |
—
|
—
|
0
|
Oct 11
| |||
Form 4
| +117.19% | 7.5K |
$5.69 | $42,675.00 | 13.9K |
Sep 4
| |||
Form 4
|
—
|
0
|
$4.94 | -$53,395.00 | 6.4K |
May 14
| |||
Form 4
|
—
|
0
|
$4.95 | -$69,920.00 | 6.4K |
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
$3.43 | -$77,600.00 | 6.4K |
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +142.86% | 2K |
$2.29 | $4,579.80 | 3.4K |
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
$5.87 | -$22,620.00 | 1.4K |
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
| No matching records found | |||||||||
Kintara Therapeutics, Inc. (HURA) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||